1) Bio-reductive antitumor drugs
生物还原抗肿瘤药物
2) Antitumor drug
抗肿瘤药物
1.
Advance of several types of important marine antitumor drugs;
几类重要的海洋抗肿瘤药物研究进展
2.
Application of polymer nanoparticles to antitumor drug delivery system;
聚合物纳米粒子作为抗肿瘤药物载体的应用
3.
Study on different educational level nursing students recognition and compliance with the occupational prevention while handling antitumor drugs;
不同学历护生对抗肿瘤药物职业防护的认知和依从性研究
3) Antineoplastic Agents
抗肿瘤药物
1.
Through analyzing the whole of using Antineoplastic Agents :the market portion,increase rate,centralize degree and calculate in 257 hospitals of the 16 national important cities in this text,we can know the Antineoplastic Agents mar.
本文通过对全国16个重点城市257家医院的抗肿瘤医院用药总体情况进行市场份额、增长率、品种潜力、各类别的抗肿瘤药物市场份额、各品种的抗肿瘤药物市场份额以及市场集中度等方面进行分析,并结合政府出台的一系列的医药政策的影响,对目前抗肿瘤药物的医院市场情况,市场未来预测以及抗肿瘤药物的未来研发方向等进行了探讨。
2.
Effects of antineoplastic agents on endocrine system are common, but it is difficult to identify since clinical complaints are subtle, and even more difficult to relate a particular chemotherapeutic regimen to the induced endocrine disturb.
抗肿瘤药物所致的内分泌紊乱在临床上并不少见,但由于其临床表现隐匿,症状错综复杂,临床上不易辨认,特别是与特定化疗药物的关系,难以鉴别。
3.
OBJECTIVE To enhance the rational drug use of intravenous antineoplastic agents.
目的促进抗肿瘤药物静脉用药的合理性。
4) anticancer drug
抗肿瘤药物
1.
Developments of naphthalimides as anticancer drugs;
萘酰亚胺类化合物作为抗肿瘤药物的研发现状
2.
Consideration on phase Ⅱ clinical trial design for anticancer drugs
抗肿瘤药物Ⅱ期临床研究设计考虑要点
3.
Bcl-2 protein is a new target of anticancer drugs with bright prospect now.
Bcl-2蛋白是目前抗肿瘤药物研究很具前景的新靶点。
5) antineoplastic drugs
抗肿瘤药物
1.
Effects of antineoplastics drug on the immune function in nurses of occupational exposure to antineoplastic drugs;
抗肿瘤药物对职业接触护士免疫功能的影响
2.
Methods: We reviewed and statistically analyzed the sales volume,sales amount,categories,DDDs of antineoplastic drugs,the changes in the sales of the local or import drugs,and similar index.
结果:抗肿瘤药物销售金额逐年上升;植物类抗肿瘤药物紫杉醇5年来销售金额均排名第一;杂类药物销售金额增长迅速,一些新型的靶向治疗药物和前体药物不断应用于临床且取得了较好的疗效。
3.
Purpose To examine the effect of iNOS on tumour cells chemosensitivity to a series of antineoplastic drugs in vitro and to clarify the possible role of iNOS in the metabolism of 2,5-biaziridinyl-6-hydroxy-methyl-3-methylbenzene-1,4-dione (RH1), a new synthesized bioreductive compound.
噻唑蓝(MTT)法比较不同酶活性的细胞克隆对顺铂等抗肿瘤药物和丝裂霉素C(MMC)衍生物-2,5-二氮丙啶-6-羟甲基-3-甲基苯-1,4-二酮(RH1)的敏感性的差异。
6) antitumor drugs
抗肿瘤药物
1.
Research of bile acids as carriers of liver targeted antitumor drugs;
以胆酸为载体的肝靶向抗肿瘤药物的研究
2.
Prevention and treatments for adverse drug reactions of antitumor drugs;
抗肿瘤药物的不良反应及防治措施
3.
OBJECTIVE: To analyze the current status and the tendency for using antitumor drugs in 150 hospitals of 6 cities.
目的分析6城市150家医院抗肿瘤药物用药的现状和趋势。
补充资料：抗代谢类抗肿瘤药物
抗代谢类抗肿瘤药物
antimetabolite agents
此类抗癌药对核酸代谢物与酶结合反应有相互竞争作用，影响与阻断了核酸的合成，如氟尿嘧啶、甲氨蝶呤、呋喃氟尿嘧啶、阿糖胞苷等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条